CDH1-associated Blepharocheilodontic Syndrome Registry

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University
Study ID
NCT07133464
Status
Recruiting
Apply to this trial

Conditions

  • Blepharocheilodontic Syndrome

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.

Key Dates

Start date
Jun 17, 2025
Status verified
Aug 2025
Primary completion
Jan 31, 2040
Completion
Jan 31, 2040

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Individuals identified as having a CDH1 variant and features of blepharocheilodontic syndrome

Primary Outcome Measure

Comprehensive characterization of the clinical phenotype associated with CDH1-associated blepharocheilodontic syndrome (BCDS) [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Ohio State UniversityColumbusOhio43221
Maegan E Roberts, MS
[email protected]
614-814-1047
Peter P Stanich, MD
[email protected]
614-814-1047
Maegan E Roberts, MS (PRINCIPAL_INVESTIGATOR)
Peter P Stanich, MD (SUB_INVESTIGATOR)

Find similar trials in Columbus, OH

By research site
The Ohio State University· Columbus, OH